Two conformational forms of target-bound iC3b that distinctively bind complement receptors 1 and 2 and two specific monoclonal antibodies

Upsala Journal of Medical Sciences

Volumn 116, Issue 1, 2011, Pages 26-33

  Nilsson, Ulf R ^a   Funke, Lillemor ^a   Nilsson, Bo ^a   Ekdahl, Kristina N ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b LINNAEUS UNIVERSITY   (Sweden)

Author keywords

Complement C3; complement receptors; immunoglobulin G (IgG); monoclonal antibodies; neo epitopes

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ADSORPTION; ARTICLE; CHEMISTRY; HUMAN; METABOLISM; PROTEIN CONFORMATION; WESTERN BLOTTING;

ADSORPTION; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; COMPLEMENT C3; COMPLEMENT C3B; HUMANS; IMMUNOGLOBULIN G; PROTEIN CONFORMATION; RECEPTORS, COMPLEMENT 3B; RECEPTORS, COMPLEMENT 3D;

EID: 79951775926     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009734.2010.528465     Document Type: Article

References (21)

1. Janssen BJ, Huizinga EG, Raaijmakers HC, Roos A, Daha MR, Ekdahl KN, et al. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature. 2005;437:505-11. (Pubitemid 41613542)
2. Janssen BJ, Christodoulidou A, McCarthy A, Lambris JD, Gros P. Structure of C3b reveals conformational changes that underlie complement activity. Nature. 2006;444:213-6. (Pubitemid 44722062)
3. Janssen BJ, Gros P. Conformational complexity of complement component C3. Adv Exp Med Biol. 2006;586:291-312.
4. Janssen BJ, Gros P. Structural insights into the central complement component C3. Mol Immunol. 2007;44:3-10. (Pubitemid 44754839)
5. Gros P, Milder FJ, Janssen BJ. Complement driven by conformational changes. Nat Rev Immunol. 2008;8:48-58.
6. Nilsson B, Svensson KE, Borwell P, Nilsson UR. Production of mouse monoclonal antibodies that detect distinct neoantigenic epitopes on bound C3b and iC3b but not on the corresponding soluble fragments. Mol Immunol. 1987;24: 487-94. (Pubitemid 17062638)
7. Nilsson B, Grossberger D, Ekdahl KN, Riegert P, Becherer D, Nilsson UR, et al. Conformational differences between surface-bound and fluid-phase complementcomponent- C3 fragments: Epitope mapping by cDNA expression. Biochem J. 1992;282:715-21.
8. Nilsson B, Ekdahl KN, Avila D, Nilsson UR, Lambris JD. Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides. Biochem J. 1990;268:55-61. (Pubitemid 20166649)
9. Ekdahl KN, Nilsson UR, Nilsson B. Inhibition of factor I by diisopropylfluorophosphate. Evidence of conformational changes in factor I induced by C3b and additional studies of the specificity of factor I. J Immunol. 1990;144:4269-74. (Pubitemid 20187768)
10. Fearon D. Cellular receptors for fragments of the third component of complement. Immunol Today. 1984;5:105-10.
11. Wong WW, Cahill JM, Rosen MD, Kennedy CA, Bonnaccio ET, Morris MJ, et al. Structure of the human CR1 gene. J Exp Med. 1989;169:847-63.
12. Toothaker LE, Henjes AJ, Weis JJ. Variability of CR2 gene products is due to alternative exon usage and different CR2 alleles. J Immunol. 1989;142:3668-75. (Pubitemid 19137505)
13. Fujisako A, Harley JB, Frank MB, Gruner BA, Frazier B, Holers VM. Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor. J Biol Chem. 1989; 264:2118-25. (Pubitemid 19057681)
14. Hammer CH, Wirtz GH, Renfer L, Gresham HD, Tack BF. Large scale isolation of functionally active components of the human complement system. J Biol Chem. 1981;256:3995-4006.
15. Fearon DT. Purification of C3b inactivator and demonstration of its two polypeptide chain structure. J Immunol. 1977; 119:1248-52. (Pubitemid 8200371)
16. Nilsson U, Müller-Eberhard H. Isolation of beta IF-globulin from human serum and its characterization as the fifth component of complement. J Exp Med. 1965;122:277-98.
17. Nilsson UR. Deposition of C3b/iC3b leads to the concealment of antigens, immunoglobulins and bound C1q in complement-activating immune complexes. Mol Immunol. 2001;38:151-60. (Pubitemid 32786773)
18. Alsenz J, Becherer D, Nilsson B, Lambris JD. Structural and functional analysis of C3 using monoclonal antibodies. Curr Top Microbiol Immunol. 1990;152:235-48.
19. de Bruijn MH, Fey GH. Human complement component C3: cDNA coding sequence and derived primary structure. Proc Natl Acad Sci U S A. 1985;82:708-12. (Pubitemid 15142747)
20. Kusano M, Choi NH, Tomita M, Yamamoto K, Migita S, Sekiya T, et al. Nucleotide sequence of cDNA and derived amino acid sequence of rabbit complement component C3 alpha-chain. Immunol Invest. 1986;15:365-78. (Pubitemid 16001325)
21. Nilsson B, Ekdahl KN, Svensson KE, Bjelle A, Nilsson UR. Distinctive expression of neoantigenic C3(D) epitopes on bound C3 following activation and binding to different target surfaces in normal and pathological human sera. Mol Immunol. 1989;26:383-90. (Pubitemid 19093457)